Alendronate Concept

subject area of

• 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.  Journal Articles
• A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists.  Journal Articles
• A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis  Journal Articles
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate on Bone Mineral Density and Bone Remodelling in Perimenopausal Women With Low Bone Mineral Density  Conferences
• A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents  Journal Articles
• A Systematic Review of the Effect of Alendronate on Bone Mineral Density in Men  Journal Articles
• A randomized controlled trial to assess alendronate‐associated injury of the upper gastrointestinal tract  Journal Articles
• Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database  Journal Articles
• Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study  Journal Articles
• Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial)  Journal Articles
• Alendronate Therapy in Men With Primary Hyperparathyroidism  Journal Articles
• Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.  Journal Articles
• Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study  Journal Articles
• Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis  Journal Articles
• Alendronate for the Treatment of Osteoporosis in Men  Journal Articles
• Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial  Journal Articles
• Are Oral Bisphosphonates Effective in Improving Lumbar Bone Mineral Density in Breast Cancer Survivors With Osteopenia or Osteoporosis?  Journal Articles
• Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?  Journal Articles
• Atypical Femoral Fractures in Patients Taking Longterm Alendronate  Journal Articles
• Bisphosphonate Therapy for Reduced Bone Mineral Density During Treatment of Acute Lymphoblastic Leukemia in Childhood and Adolescence  Journal Articles
• Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review  Journal Articles
• Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis  Journal Articles
• Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis  Journal Articles
• Cost-effectiveness of alternative treatments for women with osteoporosis in Canada  Journal Articles
• Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada  Journal Articles
• Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada  Journal Articles
• Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis  Journal Articles
• Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women  Journal Articles
• Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate  Journal Articles
• Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study  Journal Articles
• Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study  Journal Articles
• Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease  Conferences
• Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study  Journal Articles
• Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women  Journal Articles
• Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis  Journal Articles
• II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women  Journal Articles
• Impact of selective alveolar decortication on bisphosphonate burdened alveolar bone during orthodontic tooth movement  Journal Articles
• Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers  Journal Articles
• Interventions for the treatment of decreased bone mineral density associated with HIV infection  Journal Articles
• Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis  Journal Articles
• Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study  Journal Articles
• Oral bisphosphonates  Journal Articles
• Osteonecrosis of the jaw: new developments in an old disease.  Journal Articles
• Randomized Active and Placebo-Controlled Endoscopy Study of a Novel Protected Formulation of Oral Alendronate  Journal Articles
• Reduced Bone Loss Is Associated With Reduced Mortality Risk in Subjects Exposed to Nitrogen Bisphosphonates: A Mediation Analysis  Journal Articles
• Research data on alendronate: biased opinions?  Journal Articles
• Safety and Efficacy of Alendronate to Treat Osteopenia in Children During Therapy for Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of Sequential Outcomes  Journal Articles
• Similar Proportions of Women Lose Bone Mineral Density With Raloxifene or Alendronate Treatment  Journal Articles
• The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Journal Articles
• The gastrointestinal tolerability and safety of oral bisphosphonates  Journal Articles
• Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease  Journal Articles
• Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial  Journal Articles
• Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study  Journal Articles
• What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?  Journal Articles
• [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].  Journal Articles